-terol
Bronchodilators that activate beta-2 receptors, like salmeterol.
- Drugs ending in -terol: 29
- Approved somewhere: 15
- With a US drug page: 6
- Stem
- -terol
- Class
- Bronchodilators that activate beta-2 receptors, like salmeterol
- Sub-stems
- -prenaline
Approved and clinical-stage drugs in ChEMBL whose names ending in -terol or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Arformoterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Bitolterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Formoterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Indacaterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Olodaterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Pirbuterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Albuterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Clenbuterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Fenoterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Reproterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Rimiterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Salmeterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Tulobuterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Vilanterol | Approved | ADRB2 | Beta-2 adrenergic receptor agonist |
| Xamoterol | Approved | ADRB1 | Beta-1 adrenergic receptor partial agonist |
| Bambuterol | Phase 3 | ADRB2 | Beta-2 adrenergic receptor agonist |
| Procaterol | Phase 3 | ADRB2 | Beta-2 adrenergic receptor agonist |
| Abediterol | Phase 2 | ADRB2 | Beta-2 adrenergic receptor agonist |
| Batefenterol | Phase 2 | ADRB2, CHRM2, CHRM3 | Beta-2 adrenergic receptor agonist |
| Carbuterol | Phase 2 | — | — |
| Carmoterol | Phase 2 | ADRB2 | Beta-2 adrenergic receptor agonist |
| Larsucosterol | Phase 2 | — | — |
| Milveterol | Phase 2 | ADRB2 | Beta-2 adrenergic receptor agonist |
| Navafenterol | Phase 2 | ADRB2, CHRM3 | Beta-2 adrenergic receptor agonist |
| Prenalterol | Phase 2 | — | — |
| Vilanterol .alpha.-phenyl cinnamate | Phase 2 | ADRB2 | Beta-2 adrenergic receptor agonist |
| Cholesterol | Phase 1 | — | — |
| Dihydrotachysterol | — | VDR | Vitamin D receptor agonist |
| Hexoprenaline | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO